229 related articles for article (PubMed ID: 35541033)
1. Metastatic Carcinoma in Effusions.
Shidham VB
Cytojournal; 2022; 19():4. PubMed ID: 35541033
[TBL] [Abstract][Full Text] [Related]
2. Approach to Diagnostic Cytopathology of Serous Effusions.
Shidham VB; Layfield LJ
Cytojournal; 2021; 18():32. PubMed ID: 35126610
[TBL] [Abstract][Full Text] [Related]
3. Serous effusions in malignant lymphomas: a review.
Das DK
Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
[TBL] [Abstract][Full Text] [Related]
4. Introduction to the second edition of 'Diagnostic Cytopathology of Serous Fluids' as CytoJournal Monograph (CMAS) in Open Access.
Shidham VB; Layfield LJ
Cytojournal; 2021; 18():30. PubMed ID: 35126608
[TBL] [Abstract][Full Text] [Related]
5. Collection and processing of effusion fluids for cytopathologic evaluation.
Shidham VB
Cytojournal; 2022; 19():5. PubMed ID: 35541031
[TBL] [Abstract][Full Text] [Related]
6. The diagnostic yield of pleural fluid cytology in malignant pleural effusions.
Ong KC; Indumathi V; Poh WT; Ong YY
Singapore Med J; 2000 Jan; 41(1):19-23. PubMed ID: 10783675
[TBL] [Abstract][Full Text] [Related]
7. [Serous fluid cytopathology : International system: Ancillary studies for serous fluids and special considerations for peritoneal washings].
Basset C; Collin L; Vielh P; Courtade-Saïdi M;
Ann Pathol; 2023 Nov; 43(6):452-461. PubMed ID: 37640575
[TBL] [Abstract][Full Text] [Related]
8. GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimens.
Shield PW; Papadimos DJ; Walsh MD
Cancer Cytopathol; 2014 Apr; 122(4):307-12. PubMed ID: 24421220
[TBL] [Abstract][Full Text] [Related]
9. Application of the International System for Reporting Serous Fluid Cytopathology (ISRSFC) on Reporting Pericardial Effusion Cytology.
Rodriguez EF; Jones R; Gabrielson M; Santos D; Pastorello RG; Maleki Z
Acta Cytol; 2020; 64(5):477-485. PubMed ID: 32422631
[TBL] [Abstract][Full Text] [Related]
10. A Comparative Study of Liquid-Based Cytology and DNA Image Cytometry in the Diagnosis of Serous Effusion.
Wang S; Li D; Wang J; Wan Y; Huang C; Yang B; Tang X; Tian G; Yang Z
Technol Cancer Res Treat; 2020; 19():1533033820942298. PubMed ID: 32856543
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic yield of cytopathology in evaluating pericardial effusions: Clinicopathologic analysis of 419 specimens.
Saab J; Hoda RS; Narula N; Hoda SA; Geraghty BE; Nasar A; Alperstein SA; Port JL; Giorgadze T
Cancer Cytopathol; 2017 Feb; 125(2):128-137. PubMed ID: 28207201
[TBL] [Abstract][Full Text] [Related]
12. A comparative analysis of conventional cytopreparatory and liquid based cytological techniques (Sure Path) in evaluation of serous effusion fluids.
Dadhich H; Toi PC; Siddaraju N; Sevvanthi K
Diagn Cytopathol; 2016 Nov; 44(11):874-879. PubMed ID: 27546351
[TBL] [Abstract][Full Text] [Related]
13. Utility of paired box gene 8 (PAX8) expression in fluid and fine-needle aspiration cytology: an immunohistochemical study of metastatic ovarian serous carcinoma.
McKnight R; Cohen C; Siddiqui MT
Cancer Cytopathol; 2010 Oct; 118(5):298-302. PubMed ID: 20572292
[TBL] [Abstract][Full Text] [Related]
14. Static DNA cytometry as a diagnostic aid in effusion cytology: I. DNA aneuploidy for identification and differentiation of primary and secondary tumors of the serous membranes.
Motherby H; Marcy T; Hecker M; Ross B; Nadjari B; Auer H; Müller KM; Häussinger D; Strauer BE; Böcking A
Anal Quant Cytol Histol; 1998 Jun; 20(3):153-61. PubMed ID: 9642441
[TBL] [Abstract][Full Text] [Related]
15. Categorisation of serous effusions using the International System for Reporting Serous Fluid Cytopathology and assessment of risk of malignancy with diagnostic accuracy.
Ahuja S; Malviya A
Cytopathology; 2022 Mar; 33(2):176-184. PubMed ID: 34913541
[TBL] [Abstract][Full Text] [Related]
16. Indian Academy of Cytologists Guidelines for Collection, Preparation, Interpretation, and Reporting of Serous Effusion Fluid Samples.
; Srinivasan R; Rekhi B; Rajwanshi A; Pathuthara S; Mathur S; Jain D; Gupta N; Gautam U; Rai N; Nijhawan VS; Iyer V; Dey P; Deb P; Prasoon D
J Cytol; 2020; 37(1):1-11. PubMed ID: 31942091
[TBL] [Abstract][Full Text] [Related]
17. Cytohistological correlation in serous effusions using the newly proposed International System for Reporting Serous Fluid Cytopathology: Experience of an oncological center.
Lobo C; Costa J; Petronilho S; Monteiro P; Leça L; Schmitt F
Diagn Cytopathol; 2021 May; 49(5):596-605. PubMed ID: 32339444
[TBL] [Abstract][Full Text] [Related]
18. Multiple serous cavity effusion screening based on smear images using vision transformer.
Wang C; Wang X; Gao Z; Ran C; Li C; Ding C
Sci Rep; 2024 Mar; 14(1):7395. PubMed ID: 38548898
[TBL] [Abstract][Full Text] [Related]
19. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions.
Illei PB; Ladanyi M; Rusch VW; Zakowski MF
Cancer; 2003 Feb; 99(1):51-6. PubMed ID: 12589646
[TBL] [Abstract][Full Text] [Related]
20. The panorama of different faces of mesothelial cells.
Shidham VB
Cytojournal; 2021; 18():31. PubMed ID: 35126609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
